#paradromics Tech News.
2 stories in the last 7 days
The latest paradromics news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks paradromics across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Paradromics implanted its Connexus brain-computer interface in the first participant of an FDA-approved clinical study. The patient, a Michigan woman with motor neuron disease, will be followed for six years. The dime-sized device uses 421 platinum-iridium microwires to translate attempted speech into text or synthesized speech.
Paradromics completed the first surgical implantation of its Connexus BCI in the FDA-approved Connect-One Early Feasibility Study at University of Michigan Health. The device records neural signals via a high-density microelectrode array and transmits them wirelessly to an external receiver. The study evaluates long-term safety and ability to restore speech and computer control for people with severe motor impairment.
Summaries by ByteBrief